Positron Emission Tomography—the Promise of Metabolic Imaging
- 30 June 1989
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 64 (6) , 720-724
- https://doi.org/10.1016/s0025-6196(12)65355-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Validation of clinical diagnostic criteria for Alzheimer's diseaseAnnals of Neurology, 1988
- F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarctionThe American Journal of Cardiology, 1988
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomographyAmerican Heart Journal, 1987
- Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron TomographyNew England Journal of Medicine, 1986
- PET Scan Controversy AiredScience, 1984
- Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.Circulation, 1983
- Comparative localization of foci in partial epilepsy by PCT and EEGAnnals of Neurology, 1982
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilationThe American Journal of Cardiology, 1982